A protein extract and a cysteine protease inhibitor enriched fraction from Jatropha curcas seed cake have in vitro anti-Toxoplasma gondii activity

Experimental Parasitology

Volumn 153, Issue , 2015, Pages 111-117

  Soares, A M S ^a   Carvalho, L P ^b   Melo, E J T ^b   Costa, H P S ^c   Vasconcelos, I M ^c   Oliveira, J T A ^c  

^a FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

^b UNIVERSIDADE ESTADUAL DO NORTE FLUMINENSE DARCY RIBEIRO   (Brazil)

^c FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Anti T.gondii; Jatropha curcas; Papain inhibitor; Physic nut

Indexed keywords

JATROPHA CURCAS EXTRACT; ANTIPROTOZOAL AGENT; PLANT EXTRACT; PROTEINASE INHIBITOR;

ANIMAL EXPERIMENT; ANTIPROTOZOAL ACTIVITY; ARTICLE; CENTRIFUGATION; CONTROLLED STUDY; DIALYSIS; DRUG DETERMINATION; DRUG EFFECT; HOST CELL; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PH MEASUREMENT; PLANT SEED; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SOLUBILIZATION; TACHYZOITE; TOXICITY TESTING; TOXOPLASMA GONDII; VERO CELL LINE; ANIMAL; CHEMISTRY; CHLOROCEBUS AETHIOPS; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; JATROPHA; PARASITOLOGY; TOXOPLASMA; TOXOPLASMOSIS;

JATROPHA CURCAS; TOXOPLASMA; TOXOPLASMA GONDII;

ANIMALS; ANTIPROTOZOAL AGENTS; CERCOPITHECUS AETHIOPS; HUMANS; JATROPHA; MALE; PLANT EXTRACTS; PROTEASE INHIBITORS; SEEDS; TOXOPLASMA; TOXOPLASMOSIS; VERO CELLS;

EID: 84926284647     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2015.03.011     Document Type: Article

References (47)

1. Abe M., Abe K., Kuroda M., Arai S. Corn kernel cysteine proteinase inhibitor as a novel cystatin superfamily member of plant origin: molecular cloning and expression studies. Eur. J. Biochem 1992, 209:933-937.
2. Becker K. Apicomplexan parasites: Molecular approaches toward targeted drug development. Drug Discovery in Infections Diseases 2011, 550. Wiley-VCH Verlag GmbH & Co. KGaA., Weinheim. P.M. Selzer (Ed.).
3. Berg-Candolfi M., Candolfi E. Depression of the N-demethylation of erythromycin, azithromycin, clarithromycin and clindamycin in murine toxoplasma infection. Int. J. Parasitol 1996, 26(11):1321-1326.
4. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem 1976, 72:248-254.
5. Carvalho C.S., Melo E.J., Tenório R.P., Goes A.J. Anti-parasitic action and elimination of intracellular Toxoplasma gondii in the presence of novel thiosemicarbazone and 4-thiozolidinones derivates. Braz. J. Med. Biol. Res 2010, 43:139-149.
6. Choi W., Jiang M., Chu J. Antiparasitic effects of Zingiber officinale (Ginger) extract against Toxoplasma gondii. J. Appl. Biomed 2012, 11:15-26. 10.2478/v10136-012-0014-y.
7. Conseil V., Soête M., Dubremetz J.F. Serine protease inhibitors block invasion of host cells by Toxoplasma gondii. Antimicrob. Agents Chemother 1999, 43(6):1358-1361.
8. Debnath M., Binsen P.S. Jatropha curcas L., a multipurpose stress resistant plant with a potential for ethnomedicine and renewable energy. Curr. Pharm. Biotechnol 2008, 9(4):288-306.
9. Degerli K., Kilimcioglu A.A., Kurt O., Tamay A.T., Ozbilgin A. Efficacy of azithromicyn in a murine toxoplasmosis model, employing a Toxoplasma gondii strain from Turkey. Acta Trop 2003, 88(1):45-50.
10. Devappa R.K., Makkar H.P.S., Becker K. Jatropha diterpenes: a review. J. Am. Oil Chem. Soc 2011, 88:301-322. 10.1007/s11746-010-1720-9.
11. Don Z., Carruthers V.B. Proteases in Toxoplasma gondii. Cysteine Proteases of Pathogenic Organisms 2011, 49-61. Landes Bioscience - Springer Science + Business Media, LLC, Rio Grande, Austin, Texas, Chapter 4. M.W. Robison, J.P. Dalton (Eds.).
12. Dou Z., Carruthers V.B. Cathepsin proteases in Toxoplasma gondii. Adv. Exp. Med. Biol 2011, 712:49-61.
13. Dou Z., McGovern O.L., Di Cristina M., Carruthers V.B. Toxoplasma gondiiingests and digests host cytosolic proteins. mBio 2014, 5(4). e1188-e1114. 10.1128/mBio.01188-14.
14. Dubey J.P. The history of Toxoplasma gondii - The first 100 years. J. Eukaryot. Microbiol 2008, 55(6):467-475. 10.1111/j.1550-7408.2008.00345.x.
15. Dubey J.P., Lindsay D.S., Speer C.A. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin. Microbiol. Rev 1998, 11(2):267-299.
16. Georges K., Jayaprakasam B., Dalavoy S.S., Nair M.G. Pest-managing activities of plant extracts and anthraquinones from Cassia nigricans from Burkina Faso. Bioresour. Technol 2008, 6:2037-2045.
17. Gross U., Bohne W., Soête M., Dubremetz J.F. Developmental differentiation between Tachyzoites and Bradyzoites of Toxoplasma gondii. Parasitol. Today 1996, 12:30-33.
18. Hegab S.M., Al-Mutawa S.A. Immunopathogenesis of toxoplasmosis. Clin. Exp. Med 2003, 3(2):84-105.
19. Hermes G., Ajioka J.W., Kelly K.A., Mui E., Roberts F., Kasza K., et al. Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection. J. Neuroinflamation 2008, 5:48-85. 10.1186/1742-2094-5-48.
20. Holiman R.E. Toxoplasmosis, behaviour and personality. J. Infect 1997, 35:105-110.
21. Innes E.A., Vermeulen A.N. Vaccination as control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora. Parasitology 2006, 133:145-168.
22. Islam A.K.M.A., Yaakob Z., Anuar N. Jatropha: a multipurpose plant with considerable potential for the tropics. Sci. Res. Essays 2011, 6:2597-2605.
23. Joiner K.A., Roos D.S. Secretory traffic in the eukaryotic parasite Toxoplasma gondii: less is more. J. Cell Biol 2002, 157:557-563.
24. Kavitha N., Noordin R., Chan K.-L., Sreenivasan S. In vitro anti-Toxoplasma gondii activity of root extract/fraction of Eurycoma longifolia Jack. BMC Complement. Altern. Med 2012, 12:91. 10.1186/1472-6882-12-91.
25. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685. 10.1038/227680a0.
26. Liu S.Y., Sporer F., Wink M., Jourdane J., Henning R., Li Y.L., et al. Anthraquinones in Rheum palmatum and Rumex dentatus (Polygonaceae), and phorbol esters in Jatropha curcas (Euphorbiaceae) with molluscicidal activity against the schistosome vector snails Oncomelania, Biomphalaria, and Bulinus. Trop. Med. Int. Health 1997, 2:179-188.
27. Makkar H.P.S., Francis G., Becker K. Protein concentrate from Jatropha curcas screw-pressed seed cake and toxic and antinutritional factors in protein concentrate. J. Sci. Food Agric 2008, 88:1542-1548.
28. Melo E.J.T., Mayerhoffer R.O., Souza W. Hydroxyurea inhibits intracellular Toxoplasma gondii multiplication. FEMS Microbiol. Lett 2000, 185(1):79-82.
29. Melo E.J.T., Vilela K.J., Carvalho C.S. Effects of aqueous leaf extracts of Azadirachta indica A. Juss. (neem) and Melia azedarach L. (Santa Barbara or cinnamon) on the intracellular development of Toxoplasma gondii. Rev. Bras. Plantas Med 2011, 13:215-222.
30. Montoya J.G., Liesenfeld O. Toxoplasmosis. Lancet 2004, 363:1965-1976.
31. Newman D.J., Cragg G.M. Natural products as sources of new drugs over last 25 years. J. Nat. Prod 2007, 70:461-477.
32. Openshaw K. A review of Jatropha curcas: an oil plant of unfulfilled promise. Biomass Bioenergy 2000, 19:1-15.
33. Rahuman A.A., Gopalakrishnan G., Venkatesan P., Geetha K. Larvicidal activity of some Euphorbiaceae plant extracts against Aedes aegypti and Culex quinquefasciatus (Diptera: Culicidae). Parasitol. Res 2008, 102:867-873.
34. Renslo A.R., McKerrow J.H. Drug discovery and development for neglected parasitic diseases. Nat. Chem. Biol 2006, 2:701-710.
35. Saadatnia G., Haj Ghani H., Khoo B.Y., Maimunah A., Rahmah N. Optimization of Toxoplasma gondii cultivation in Vero cell line. Trop. Biomed 2010, 27:125-130.
36. Schmook B., Serralta-Peraza L. J. curcas: Distribution and uses in the Yucatan Peninsula of Mexico. Biofuels and Industrial Products from Jatropha curcas 1997, 53-57. Nicaragua. G.M. Gubitz, M. Mittelbach, M. Trabi (Eds.).
37. Sharma N., Trivedi P.C. Screening of leaf extracts of some plants for their nematicidal and fungicidal properties against Meloidogyne incognita and Fusarium oxysporum. Asian J. Exp. Sci 2002, 16:21-28.
38. Shaw M.K., Ross D.S., Tilney L.G. Cysteine and serine protease inhibitors block intracellular development and disrupt the secretory pathway of Toxoplasma gondii. Microbes Infect 2002, 4:119-132.
39. Sibley L.D. Invasion strategies of intracellular parasites. Science 2004, 304:248-253.
40. Sinai A.P. Biogenesis of and activities at the Toxoplasma gondii parasitophorous vacuole membrane. Molecular Mechanisms of Parasite Invasion 2008, 237. Landes Bioscience, Texas. B.A. Burleigh, D. Soldati-Favre (Eds.).
41. Tenter A.M., Heckeroth A.R., Weiss L.M. Toxoplasma gondii: from animals to humans. Int. J. Parasitol 2000, 30:1217-1258.
42. Teo C.H., Zhou X.W., Bogyo M., Carruthers V.B. Cysteine protease inhibitors block Toxoplasma gondii microneme secretion and cell invasion. Antimicrob. Agents Chemother 2007, 51:679-688.
43. Vasconcelos I.M., Trentim A., Guimarães J.A., Carlini C.R. Purification and physicochemical characterization of soyatoxin, a novel toxic protein isolated from soybean (Glycine max). Arch. Biochem. Biophys 1994, 312:357-366.
44. Weber K., Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J. Biol. Chem 1969, 214:4406-4412.
45. Wink M., Koschmieder C., Sauerwein M., Sporer F. Phorbol esters of Jatropha curcas - biological activities and potential applications. Biofuel and Industrial Products from Jatropha curcas 1997, 160-167. Nicaragua. G.M. Gübitz, M. Mittelbach, M. Trabi (Eds.).
46. Yang X., Huang B., Chen J., Huang S., Zheng H., Lun Z., et al. In vitro effects of aqueous extracts of Astragalus membranaceus and Scutellaria baicalensis Georgi on Toxoplasma gondii. Parasitol. Res 2012, 110:2221-2227.
47. Youn H.J., Lakritz J., Kim D.Y., Rottinghaus G.E., Marsh A.E. Anti-protozoal efficacy of medicinal herb extracts against Toxoplosma gondii and Neospora caninum. Vet. Parasitol 2003, 116:7-14.